Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity

Frontiers in Pharmacology

Volumn 8, Issue , 2017, Pages

  Biagioli, Michele ^a   Laghi, Luca ^b   Carino, Adriana ^a   Cipriani, Sabrina ^a   Distrutti, Eleonora ^c   Marchianò, Silvia ^a   Parolin, Carola ^d   Scarpelli, Paolo ^a   Vitali, Beatrice ^d   Fiorucci, Stefano ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Animal studies; Cytokines and inflammation; Inflammatory bowel diseases; Intestinal permeability; Macrophage activation; Metabolomics metabolite profiling; Probiotics; RAGE receptor

Indexed keywords

DIHYDROXYACETONE; DOCUSATE SODIUM; FRUCTOSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; OCCLUDIN; PROBIOTIC AGENT; PROTEIN ZO1; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CARBOHYDRATE METABOLISM; CLINICAL FEATURE; COLITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MODEL; DRUG FORMULATION; FEMALE; INTESTINE METABOLISM; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; MACROPHAGE; MALE; METABOLOMICS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SPECIES DIFFERENCE; STREPTOCOCCUS THERMOPHILUS; SUPERNATANT; TISSUE METABOLISM; UNITED KINGDOM;

EID: 85034050701     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00505     Document Type: Article

References (37)

1. Andrassy, M., Igwe, J., Autschbach, F., Volz, C., Remppis, A., Neurath, M. F., et al. (2006). Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am. J. Pathol. 169, 1223-1237. doi: 10.2353/ajpath.2006.050713
2. Barbara, G., Scaioli, E., Barbaro, M. R., Biagi, E., Laghi, L., Cremon, C., et al. (2016). Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut 66, 1175-1176. doi: 10.1136/gutjnl-2016-312377
3. Bellaguarda, E., and Chang, E. B. (2015). IBD and the gut microbiota-from bench to personalized medicine. Curr. Gastroenterol. Rep. 17:15. doi: 10.1007/s11894-015-0439-z
4. Bierhaus, A., and Nawroth, P. P. (2009). Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 52, 2251-2263. doi: 10.1007/s00125-009-1458-9
5. Chibbar, R., and Dieleman, L. A. (2015). Probiotics in the management of Ulcerative colitis. J. Clin. Gastroenterol. 49, S50-S55. doi: 10.1097/MCG.0000000000000368
6. Cinque, B., La Torre, C., Lombardi, F., Palumbo, P., Van der Rest, M., Cifone, M. G., et al. (2016). Production conditions affect the in vitro anti-tumoral effects of a high concentration multi-strain probiotic preparation. PLoS ONE 11:e0163216. doi: 10.1371/journal.pone.0163216
7. Corcoran, B. M., Stanton, C., Fitzgerald, G. F., and Ross, R. P. (2007). Growth of prebiotico lactobacilli in the presence of oleic acid enhances subsequent survival in gastric juice.Microbiology 153, 291-299. doi: 10.1099/mic.0.28966-0
8. Corridoni, D., Pastorelli, L., Mattioli, B., Locovei, S., Ishikawa, D., Arseneau, K. O., et al. (2012). Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. PLoS ONE 7:e42067. doi: 10.1371/journal.pone.0045425
9. de Souza, H. S., and Fiocchi, C. (2016). Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13, 13-27. doi: 10.1038/nrgastro.2015.186
10. Dieterle, F., Ross, A., Schlotterbeck, G., and Senn, H. (2006). Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal. Chem. 78, 4281-4290. doi: 10.1021/ac051632c
11. Distrutti, E., Cipriani, S., Mencarelli, A., Renga, B., and Fiorucci, S. (2013). Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. PLoS ONE 8:e63893. doi: 10.1371/journal.pone.0063893
12. Distrutti, E., O'Reilly, J. A., McDonald, C., Cipriani, S., Renga, B., Lynch, M. A., et al. (2014).Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS ONE 9:e106503. doi: 10.1371/journal.pone.0106503
13. Endo, Y., Kamisada, S., Fujimoto, K., and Saito, T. (2006). Trans fatty acids promote the growth of some Lactobacillus strains. J. Gen. Appl. Microbiol. 52, 29-35. doi: 10.2323/jgam.52.29
14. Fritz, G. (2011). RAGE: a single receptor fits multiple ligands. Trends Biochem. Sci. 36, 625-632. doi: 10.1016/j.tibs.2011.08.008
15. Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K. M., Brigidi, P., et al. (2003). Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124, 1202-1209. doi: 10.1016/S0016-5085(03)00171-9
16. Gionchetti, P., Rizzello, F., Venturi, A., Venturi, A., Brigidi, P., Matteuzzi, D., et al. (2000). Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 305-309. doi: 10.1053/gast.2000.9370
17. Grangette, C., Nutten, S., Palumbo, E., Morath, S., Hermann, C., Dewulf, J., et al. (2005). Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. U.S.A. 102, 10321-10326. doi: 10.1073/pnas.0504084102
18. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., et al. (2014). Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506-514. doi: 10.1038/nrgastro.2014.66
19. Liland, K. H., Almøy, T., and Mevik, B. H. (2010). Optimal choice of baseline correction for multivariate calibration of spectra. Appl. Spectrosc. 64, 1007-1016. doi: 10.1366/000370210792434350
20. Lorén, V., Manyé, J., Fuentes, M. C., Cabré, E., Ojanguren, I., Espadaler, J., et al. (2010). Comparative effect of the I3.1 probiotic formula in two animal models of colitis. Probiotics Antimicrob. Proteins 9, 71-80. doi: 10.1007/s12602-016-9239-5
21. Maassen, C. B., Boersma, W. J., van Holten-Neelen, C., Claassen, E., and Laman, J. D. (2003). Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development. Vaccine 21, 2751-2757. doi: 10.1016/S0264-410X(03)00220-2
22. Mencarelli, A., Cipriani, S., Francisci, D., Santucci, L., Baldelli, F., Distrutti, E., et al. (2016). Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis. Sci. Rep. 6:30802. doi: 10.1038/srep30802
23. Mencarelli, A., Cipriani, S., Renga, B., Bruno, A., D'Amore, C., Distrutti, E., et al. (2012). VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS ONE 7:e45425. doi: 10.1371/journal.pone.0045425
24. Mencarelli, A., Distrutti, E., Renga, B., D'Amore, C., Cipriani, S., Palladino, G., et al. (2011). Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. PLoS ONE 6:e22978. doi: 10.1371/journal.pone.0022978
25. Mosli, M. H., Rivera-Nieves, J., and Feagan, B. G. (2014). T-cell trafficking and anti-adhesion strategies in inflammatory bowel disease: current and future prospects. Drugs 74, 297-311. doi: 10.1007/s40265-013-0176-2
26. Neurath, M. F. (2017). Current and emerging therapeutic targets for IBD. Nat. Rev. Gastroenterol. Hepatol. 14, 269-278. doi: 10.1038/nrgastro.2016.208
27. Obeid, O. A., Bittar, S. T., Hwalla, N., and Emery, P. W. (2005). Effect of diet supplementation with glutamine, dihydroxyacetone, and leucine on food intake, weight gain, and postprandial glycogen metabolism of rats. Nutrition 21, 224-229. doi: 10.1016/j.nut.2004.03.026
28. Obeid, O. A., Jamal, Z. M., Hwalla, N., and Emery, P. W. (2006). The effect of glutamine and dihydroxyacetone supplementation on food intake, weight gain, and postprandial glycogen synthesis in female Zucker rats. Nutrition 22, 794-801. doi: 10.1016/j.nut.2006. 04.004
29. Ohgami, N., Nagai, R., Ikemoto, M., Arai, H., Kuniyasu, A., Horiuchi, S., et al. (2001). Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J. Biol. Chem. 276, 3195-3202. doi: 10.1074/jbc.M006545200
30. Pagnini, C., Saeed, R., Bamias, G., Arseneau, K. O., Pizarro, T. T., Cominelli, F., et al. (2010). Probiotics promote gut health through stimulation of epithelial innate immunity. Proc. Natl. Acad. Sci. U. S. A. 107, 454-459. doi: 10.1371/journal.pone.0042067
31. Parolin, C., Marangoni, A., Laghi, L., Foschi, C., ñahui Palomino, R. A., Calonghi, N., et al. (2015). Isolation of vaginal Lactobacilli and characterization of anti-Candida activity. PLoS ONE 22:10:e0131220. doi: 10.1371/journal.pone.0131220
32. Phillips, S. A., and Thornalley, P. J. (1993). Formation of methylglyoxal and D-lactate in human red blood cells in vitro. Biochem. Soc. Trans. 21:163S. doi: 10.1042/bst021163s
33. Sashihara, T., Sueki, N., Furuichi, K., and Ikegami, S. (2007). Effect of growth conditions of Lactobacillus gasseri OLL2809 on the immunostimulatory activity for production of interleukin-12 (p70) by murine splenocytes. Int. J. Food Microbiol. 120, 274-281. doi: 10.1016/j.ijfoodmicro.2007. 09.003
34. Shen, J., Zuo, Z. X., and Mao, A. P. (2014). Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm. Bowel Dis. 20, 21-35. doi: 10.1097/01.MIB.0000437495. 30052.be
35. Thornalley, P. J. (2003). Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem. Soc. Trans. 31, 1343-1348. doi: 10.1042/bst0311343
36. Toshimitsu, T., Ozaki, S., Mochizuki, J., Furuichi, K., and Asami, Y. (2017). Effects of Lactobacillus plantarum strain OLL2712 culture conditions on the anti-inflammatory activities for murine immune cells and obese and type 2 diabetic mice. Appl. Environ. Microbiol. 83:e03001-16. doi: 10.1128/AEM. 03001-16
37. van Baarlen, P., Troost, F. J., van Hemert, S., van der Meer, C., de Vos, W. M., de Groot, P. J., et al. (2008). Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl. Acad. Sci. U.S.A. 106, 2371-2376. doi: 10.1073/pnas.0809919106